Literature DB >> 33273184

HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.

Maja C Ziegler1, Kewreshini Naidoo2, Anais Chapel1, Sindiswa Nkotwana2, Jaclyn Mann2, Zenele Mncube2, Nasreen Ismael2, Philip Goulder2,3, Thumbi Ndung'u2,4,5,6,7, Marcus Altfeld1,2, Christina F Thobakgale2,8.   

Abstract

: HIV-1 sequence variations impact binding of inhibitory killer cell immunoglobulin-like receptors (KIRs) to human leukocyte antigen class I (HLA-I) molecules modulating natural killer cell function. HIV-1 strains encoding amino acids that mediate binding of inhibitory KIRs might therefore have a selective benefit in individuals expressing the respective KIR/HLA genotypes. Here, we demonstrate that HIV-1 clade C avoids a p24 Gag mutation that abolishes binding of KIR2DL2 to HLA-C03:04 and disinhibits natural killer cells in individual encoding for this genotype.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33273184      PMCID: PMC7856308          DOI: 10.1097/QAD.0000000000002721

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  11 in total

1.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.

Authors:  J C Boyington; S A Motyka; P Schuck; A G Brooks; P D Sun
Journal:  Nature       Date:  2000-06-01       Impact factor: 49.962

Review 2.  NK cell recognition.

Authors:  Lewis L Lanier
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

3.  HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C12:02/C14:03.

Authors:  Zhansong Lin; Kimiko Kuroki; Nozomi Kuse; Xiaoming Sun; Tomohiro Akahoshi; Ying Qi; Takayuki Chikata; Takuya Naruto; Madoka Koyanagi; Hayato Murakoshi; Hiroyuki Gatanaga; Shinichi Oka; Mary Carrington; Katsumi Maenaka; Masafumi Takiguchi
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

4.  Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.

Authors:  Nienke H van Teijlingen; Angelique Hölzemer; Christian Körner; Wilfredo F García-Beltrán; Jamie L Schafer; Lena Fadda; Todd J Suscovich; Christian Brander; Mary Carrington; David T Evans; Debbie van Baarle; Marcus Altfeld
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

5.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Authors:  Maureen P Martin; Ying Qi; Xiaojiang Gao; Eriko Yamada; Jeffrey N Martin; Florencia Pereyra; Sara Colombo; Elizabeth E Brown; W Lesley Shupert; John Phair; James J Goedert; Susan Buchbinder; Gregory D Kirk; Amalio Telenti; Mark Connors; Stephen J O'Brien; Bruce D Walker; Peter Parham; Steven G Deeks; Daniel W McVicar; Mary Carrington
Journal:  Nat Genet       Date:  2007-05-13       Impact factor: 38.330

6.  Increased natural killer cell activity in viremic HIV-1 infection.

Authors:  Galit Alter; Jessica M Malenfant; Rosemary M Delabre; Nicole C Burgett; Xu G Yu; Mathias Lichterfeld; John Zaunders; Marcus Altfeld
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

7.  Adaptation of HIV-1 to human leukocyte antigen class I.

Authors:  Yuka Kawashima; Katja Pfafferott; John Frater; Philippa Matthews; Rebecca Payne; Marylyn Addo; Hiroyuki Gatanaga; Mamoru Fujiwara; Atsuko Hachiya; Hirokazu Koizumi; Nozomi Kuse; Shinichi Oka; Anna Duda; Andrew Prendergast; Hayley Crawford; Alasdair Leslie; Zabrina Brumme; Chanson Brumme; Todd Allen; Christian Brander; Richard Kaslow; James Tang; Eric Hunter; Susan Allen; Joseph Mulenga; Songee Branch; Tim Roach; Mina John; Simon Mallal; Anthony Ogwu; Roger Shapiro; Julia G Prado; Sarah Fidler; Jonathan Weber; Oliver G Pybus; Paul Klenerman; Thumbi Ndung'u; Rodney Phillips; David Heckerman; P Richard Harrigan; Bruce D Walker; Masafumi Takiguchi; Philip Goulder
Journal:  Nature       Date:  2009-02-25       Impact factor: 49.962

8.  HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.

Authors:  Lena Fadda; Christian Körner; Swati Kumar; Nienke H van Teijlingen; Alicja Piechocka-Trocha; Mary Carrington; Marcus Altfeld
Journal:  PLoS Pathog       Date:  2012-07-12       Impact factor: 6.823

9.  Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.

Authors:  Malcolm J W Sim; Stacy A Malaker; Ayesha Khan; Janet M Stowell; Jeffrey Shabanowitz; Mary E Peterson; Sumati Rajagopalan; Donald F Hunt; Daniel M Altmann; Eric O Long; Rosemary J Boyton
Journal:  Front Immunol       Date:  2017-03-14       Impact factor: 7.561

10.  Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.

Authors:  Angelique Hölzemer; Christina F Thobakgale; Camilo A Jimenez Cruz; Wilfredo F Garcia-Beltran; Jonathan M Carlson; Nienke H van Teijlingen; Jaclyn K Mann; Manjeetha Jaggernath; Seung-gu Kang; Christian Körner; Amy W Chung; Jamie L Schafer; David T Evans; Galit Alter; Bruce D Walker; Philip J Goulder; Mary Carrington; Pia Hartmann; Thomas Pertel; Ruhong Zhou; Thumbi Ndung'u; Marcus Altfeld
Journal:  PLoS Med       Date:  2015-11-17       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.